EXOMIND & rTMS Research Library
TMS can influence cortical excitability and connected brain networks, but evidence for treating cognitive impairment must not be converted into guaranteed enhancement claims for healthy people.
Why this finding matters
TMS can influence cortical activity and connected networks, which is scientifically meaningful. However, changes in brain excitability do not automatically translate into guaranteed memory, focus or performance gains.
Research Spotlight
Effects depend on population and protocol
- Cognitive domains vary
- Clinical populations dominate
- Targets differ
- Wellness claims remain limited
What the evidence suggests
Meta-analytic research across brain disorders reports cognitive effects that vary by diagnosis, stimulation target, frequency and outcome. Some clinical populations show improvement, while evidence for broad enhancement in healthy adults is less established.
What this could mean for you
At Calgary Mind & Wellness Clinic, brain-optimization goals are approached through assessment, functional targets and integrated care rather than a promise of generalized cognitive enhancement.
A careful, individualized next step
Research informs—but does not replace—individual clinical judgment. We review symptoms, diagnosis, previous treatment, medications, contraindications, functional goals and the strength of evidence for the proposed protocol. A consultation does not guarantee that treatment will be recommended.
Define a measurable brain-health goal
A consultation helps separate clinically supported treatment targets from broader wellness claims and identifies outcomes that can be monitored responsibly.
Book a Consultation Explore the related Calgary service
Related Calgary service: EXOMIND rTMS Calgary
Study citation
Begemann et al. Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis. PMID: 36857011.
View the original record on PubMed
Educational information only. Findings from pooled research do not predict individual outcomes and may involve devices or protocols that differ from EXOMIND.